Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Fast and simple method for generating amplified cDNA from 5–100 ng of whole blood total RNA in about 4 hours.
***************************************************************************************
***************************************************************************************
Tab 01 / Overview
***************************************************************************************
***************************************************************************************
The Ovation® Whole Blood Solution is comprised of a set of optimized kits and protocols to enable gene expression analysis of whole blood total RNA without the need for globin reduction procedures.
The Ovation® Whole Blood Solution utilizes two kits for amplification of whole blood total RNA and one kit for the preparation of labeled target. The amplification process is powered by SPIA®, a proprietary technology developed by Tecan.
The Ovation® Whole Blood Solution kits provide optimized reagent mixes and protocols to process 60 RNA samples and are also available in 96 reaction sizes for automation workflows.
***************************************************************************************
***************************************************************************************
Tab 02 / Highlights
***************************************************************************************
***************************************************************************************
Duplicate samples were prepared from 20 ng of human whole blood RNA using the Ovation Whole Blood Solution, according to the product user guides. RNA samples were isolated using the Agencourt RNAdvance™ Blood kit on the Beckman ArrayPlex. Targets were hybridized to Affymetrix GeneChip®U133_plus_2.0 arrays. Results of linear regression analysis show a strong signal correlation of R = 0.992, with 58% present calls, demonstrating very high reproducibility across transcript abundance with only 20 ng of input total whole blood RNA.
Duplicate samples were prepared from 20 ng of human whole blood RNA using the Ovation Whole Blood Solution, according to the product user guides. RNA samples were isolated using the Agencourt RNAdvance™ Blood kit on the Beckman ArrayPlex. Targets were hybridized to Affymetrix GeneChip®U133_plus_2.0 arrays. Results of linear regression analysis show a strong signal correlation of R = 0.992, with 58% present calls, demonstrating very high reproducibility across transcript abundance with only 20 ng of input total whole blood RNA.
***************************************************************************************
***************************************************************************************
Tab 03 / Specifications
***************************************************************************************
***************************************************************************************
Specification |
Specification/Description |
---|---|
Compatible Platform |
Compatible Platform Affymetrix GeneChip Arrays, Illumina BeadChips, Agilent Dual Mode Array |
Amplification Type |
Amplification Type Initiated at the 3’ end |
Starting Material |
Starting Material Total RNA |
Input Amounts |
Input Amounts 5 – 100 ng |
***************************************************************************************
***************************************************************************************
Tab 04 / Faq
***************************************************************************************
***************************************************************************************
Yes. Our studies have included sample-to-sample, lot-to-lot and operator-to-operator reproducibility. Refer to the Tecan Technical Report on Encore Biotin Module Performance for a summary of our performance data.
We recommend a column-based method, including:
We do not recommend the use of TRIzol® or similar methods as any carry over of organic solvents may inhibit downstream enzyme activity. If using TRIzol extracted RNA, we recommend using a column-based purification of the RNA prior to input into the kit.
We do not recommend the use of carriers during RNA isolation. If a carrier is required, please contact Technical Support for more information.
Yes. Use of lower quality RNA may result in poor performance. One approach to determining RNA quality is the Agilent Bioanalyzer’s RNA Integrity Number (RIN). Clean RNA with a RIN score greater than 7 should amplify well.
We recommend RNA input of 5–100ng RNA from whole blood or total cellular RNA; however, due to the high levels of globin present in whole blood RNA samples, we advise using inputs of 20 ng or higher when feasible.
We do not specifically require one method of RNA preparation, however, for whole blood samples the QIAGEN PAXgene products for stabilization and RNA isolation have been validated and are compatible with the Ovation Whole Blood Solution. In general, any method that yields high quality, non-degraded RNA that is free of organic solvents and contaminants should work well.
No.
We do not recommend stopping at any step of the protocol.
The labeled cDNA should be stored at –20°C. Ensure the vials are well sealed and avoid multiple freeze/thaw cycles.
RNAClean XP beads are certified to be RNase and DNase free. We have tested both RNAClean XP and AMPure XP beads in our kits and observe no difference in performance between products.
Due to the large number of commercially available magnets, we do not have a comprehensive list of compatible products. However, many magnets are compatible. As long as the magnet is strong enough to clear the solution of magnetic beads, it can be applied to the system. We have the following guidelines for selecting a magnetic separation device:
The total yield of cDNA is not directly dependent upon input RNA amount due to upper limit constraints on cDNA production in the reaction.
Yes. The primers and reagents present in the amplified cDNA will interfere with accurate quantitation. Details on measuring the concentration of cDNA are included in the User Guide.
You may use an Agilent Bioanalyzer to inspect the size distribution of samples before and after fragmentation as described in Appendix B.
The Encore Biotin Module provides all necessary buffers and enzymes for fragmentation and labeling of cDNA generated by the Ovation Whole Blood Solution.
Since the Encore Biotin Module does not require any purification, the final yield is equal to the amount of cDNA input.
As measured with an Agilent Bioanalyzer, 80% of product falls below 200 bases with an average peak at 85 bases.
No. Purification of the labeled cDNA is not necessary.
No. Refer to Appendix C for information on recommended array hybridization reagents.
Refer to Appendix C for information on array hybridization protocols.
***************************************************************************************
***************************************************************************************
Tab 05 / Literature
***************************************************************************************
***************************************************************************************
Single Primer Isothermal Amplification (SPIA) technology provides industry leading...
Provides a rapid, simple and easily automatable approach for fragmentation and labeling...
For research use only. Not for use in diagnostic procedures.